<VariationArchive VariationID="1458506" VariationName="NM_000426.4(LAMA2):c.9168_9169dup (p.Ser3057fs)" VariationType="Duplication" Accession="VCV001458506" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1468217" VariationID="1458506">
      <GeneList>
        <Gene Symbol="LAMA2" FullName="laminin subunit alpha 2" GeneID="3908" HGNC_ID="HGNC:6482" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="128883138" stop="129516566" display_start="128883138" display_stop="129516566" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129204285" stop="129837710" display_start="129204285" display_stop="129837710" Strand="+" />
          </Location>
          <OMIM>156225</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000426.4(LAMA2):c.9168_9169dup (p.Ser3057fs)</Name>
      <CanonicalSPDI>NC_000006.12:129514551:AT:ATAT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="129514551" stop="129514552" display_start="129514551" display_stop="129514552" variantLength="2" positionVCF="129514551" referenceAlleleVCF="C" alternateAlleleVCF="CAT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129835696" stop="129835697" display_start="129835696" display_stop="129835697" variantLength="2" positionVCF="129835696" referenceAlleleVCF="C" alternateAlleleVCF="CAT" />
      </Location>
      <ProteinChange>S3057fs</ProteinChange>
      <ProteinChange>S3053fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_409" sequenceAccession="LRG_409">
            <Expression>LRG_409:g.636412_636413dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.129835697_129835698dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.129835697_129835698dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.129514552_129514553dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.129514552_129514553dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008678.1" sequenceAccession="NG_008678" sequenceVersion="1" change="g.636412_636413dup">
            <Expression>NG_008678.1:g.636412_636413dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000426.4" sequenceAccession="NM_000426" sequenceVersion="4" change="c.9168_9169dup" MANESelect="true">
            <Expression>NM_000426.4:c.9168_9169dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000417.3" sequenceAccession="NP_000417" sequenceVersion="3" change="p.Ser3057fs">
            <Expression>NP_000417.3:p.Ser3057fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079823.2" sequenceAccession="NM_001079823" sequenceVersion="2" change="c.9156_9157dup">
            <Expression>NM_001079823.2:c.9156_9157dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073291.2" sequenceAccession="NP_001073291" sequenceVersion="2" change="p.Ser3053fs">
            <Expression>NP_001073291.2:p.Ser3053fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2114939796" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000426.4(LAMA2):c.9168_9169dup (p.Ser3057fs) AND LAMA2-related muscular dystrophy" Accession="RCV001956405" Version="3">
        <ClassifiedConditionList TraitSetID="9616">
          <ClassifiedCondition DB="MedGen" ID="C5679788">LAMA2-related muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16601" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">LAMA2-related muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0100228" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Laminin alpha 2-related dystrophy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LAMA2-RD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy type 1A (MDC1A) to milder late-onset LAMA2-MD. MDC1A is typically characterized by neonatal profound hypotonia, poor spontaneous movements, and respiratory failure. Failure to thrive, gastroesophageal reflux, aspiration, and recurrent chest infections necessitating frequent hospitalizations are common. As disease progresses, facial muscle weakness, temporomandibular joint contractures, and macroglossia may further impair feeding and can affect speech. In late-onset LAMA2-MD onset of manifestations range from early childhood to adulthood. Affected individuals may show muscle hypertrophy and develop a rigid spine syndrome with joint contractures, usually most prominent in the elbows. Progressive respiratory insufficiency, scoliosis, and cardiomyopathy can occur.</Attribute>
                <XRef ID="NBK97333" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="C5679788" DB="MedGen" />
              <XRef ID="MONDO:0100228" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4263468" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14271232|MedGen:CN117977" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002238456" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser3057Tyrfs*23) in the LAMA2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 66 amino acid(s) of the LAMA2 protein. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the LAMA2 protein in which other variant(s) (p.Lys3074Asnfs*5) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with LAMA2-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.129835696_129835697insAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN117977" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4263468" TraitType="Disease" MappingType="XRef" MappingValue="CN117977" MappingRef="MedGen">
        <MedGen CUI="C5679788" Name="LAMA2-related muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

